← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-11 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
AntibodystaleRochePhase 2

rituximab (Rituxan, Rituxan (rituximab))

Rheumatoid Arthritis · Lupus Erythematosus, Systemic

#LupusErythematosusSystemic#Antibody#Phase2#항체#면역항체+3
임상시험 2상태 ACTIVE
AntibodystaleRocheApproved

Rituximab Infusion (Rituximab Infusion)

Multiple Sclerosis · Nephrotic Syndrome

#NephroticSyndrome#Antibody#Approved#항체#면역항체+3
임상시험 2상태 ACTIVE
AntibodystaleRochePhase 2

Rituximab/Gemcitabine/Oxaliplatin (Rituximab/Gemcitabine/Oxaliplatin)

Refractory Aggressive Non-Hodgkin's Lymphoma; Relapsing Aggressive Non-Hodgkin's Lymphoma · Combination Therapy

#CombinationTherapy#Antibody#Phase2#항체#면역항체+4
효능 ORR 69.7%임상시험 2상태 RECRUITING
AntibodystaleMerck Sharp & Dohme LLCPhase 2

Robatumumab (Robatumumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 2상태 DISCONTINUED
ADCBiologicstaleSilverback TherapeuticsPhase 2

SBT6050 (SBT6050)

HER2-positive Breast Cancer; HER2-positive Gastric Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 1%임상시험 2상태 ACTIVE
CGTBiologicSeattle Children's HospitalPhase 1

SC-CAR.GPC3xIL15.21 CAR T cells (SC-CAR.GPC3xIL15.21 CAR T cells)

Solid Tumor (Excluding CNS); Liver Cell Carcinoma · Solid Tumor (Excluding CNS)

#SolidTumorExcludingCNS#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 2상태 RECRUITING
CGTBiologicSana BiotechnologyPhase 1

SC291 (SC291)

Non Hodgkin Lymphoma; Chronic Lymphocytic Leukemia · Lupus Erythematosus

#LupusErythematosus#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 2상태 RECRUITING
ADCBiologicstaleSeagen Inc.Phase 1

SEA-TGT (SEA-TGT)

Non-small Cell Lung Cancer; Gastric Carcinoma · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 33.3%임상시험 2상태 DISCONTINUED
ADCBiologicstaleSeagen Inc.Phase 1

SGN-75 (SGN-75)

Renal Cell Carcinoma · Carcinoma, Renal Cell

#CarcinomaRenalCell#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 DISCONTINUED
ADCBiologicstaleJiangsu HengRui Medicine Co., L…Phase 2

SHR-1316 (SHR-1316)

Breast Neoplasm; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 RECRUITING
ADCBiologicstaleMarengo Therapeutics, Inc.Phase 2

STAR0602 (STAR0602)

Triple Negative Locally Advanced Non-resectable Breast Cancer; HR+, HER2-, Advanced Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
임상시험 2상태 RECRUITING
ADCBiologicstaleByondis B.V.Phase 1

SYD985 + Niraparib (SYD985 + Niraparib)

Solid Tumor · Solid Tumor

#SolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 2상태 ACTIVE
ADCBiologicstaleCSPC Megalith Biopharmaceutical…Phase 2

SYS6023 (SYS6023)

Advanced Breast Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
CGTBiologicstaleGuangdong ProCapZoom Bioscience…Phase 1

SZ011 CAR-NK (SZ011 CAR-NK)

Advanced Triple Negative Breast Cancer · Advanced Triple Negative Breast Cancer

#AdvancedTripleNegativeBreastCanc#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 2상태 RECRUITING
AntibodystaleNovartis PharmaceuticalsPreclinical

Secikinumab (Secikinumab)

Axial Spondylarthritis (axSpA); Secukinumab · Psoriasis

#Psoriasis#Antibody#Preclinical#항체#면역항체+4
임상시험 2상태 ACTIVE
ADCBiologicstaleEli Lilly and CompanyPhase 3

Sofetabart Mipitecan (Sofetabart Mipitecan)

Ovarian Neoplasms; Fallopian Tube Neoplasms · Ovarian Neoplasms

#OvarianNeoplasms#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
CGTAAVBiologicstaleNeurologix, Inc.Phase 1

Surgical infusion of AAV-GAD into the subthalamic nucleus (Surgical infusion of AAV-GAD into the subthalamic nucleus)

Parkinson's Disease · Parkinson's Disease

#ParkinsonsDisease#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 2상태 ACTIVE
CGTBiologicstaleMiltenyi Biomedicine GmbHPhase 1

T-cell Receptor-engineered T-cells (T-cell Receptor-engineered T-cells)

Prostate Carcinoma; Prostate Small Cell Neuroendocrine Carcinoma · Metastatic Malignant Solid Neoplasm

#MetastaticMalignantSolidNeoplasm#CGT#Phase1#세포유전치료#CAR-T+4
효능 ORR 32%임상시험 2상태 RECRUITING
ADCBiologicstaleTCRCure Biopharma Ltd.Phase 2

TC-N201 (TC-N201)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
CGTBiologicstaleTScan Therapeutics, Inc.Phase 1

TCR-T cells targeting MAGE-A4 (TCR-T cells targeting MAGE-A4)

Advanced Mesenchymal Malignancies · Advanced Mesenchymal Malignancies

#AdvancedMesenchymalMalignancies#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 2상태 RECRUITING

72 / 209 페이지

← 이전다음 →